Beijing Beilu Pharmaceutical Long-term Investment Intensity
Beijing Beilu Pharmaceutical long-term investment intensity. Beijing Beilu Pharmaceutical (300016) has a Long-term Investment Intensity of 39.8% as of December 2019. Long-term investments of CN¥645.69 Million represent 39.8% of total assets of CN¥1.62 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Beijing Beilu Pharmaceutical current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Beijing Beilu Pharmaceutical (2015–2019)
Long-term investment intensity of Beijing Beilu Pharmaceutical from 2015 to 2019. This chart shows how Beijing Beilu Pharmaceutical's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 39.8%, reflecting long-term investments of CN¥645.69 Million against total assets of CN¥1.62 Billion CNY. See 300016 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Beijing Beilu Pharmaceutical Long-term Investment Intensity by Year (2015–2019)
Beijing Beilu Pharmaceutical long-term investment intensity by year from 2015 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Beijing Beilu Pharmaceutical from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Beijing Beilu Pharmaceutical assets under control.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 39.8% | CN¥645.69 Million | CN¥1.62 Billion | ▲ +4.6 pp |
| 2018 | 35.1% | CN¥452.54 Million | CN¥1.29 Billion | ▲ +9.3 pp |
| 2017 | 25.8% | CN¥293.98 Million | CN¥1.14 Billion | ▲ +2.5 pp |
| 2016 | 23.2% | CN¥222.18 Million | CN¥956.09 Million | ▲ +19.5 pp |
| 2015 | 3.8% | CN¥39.73 Million | CN¥1.05 Billion | — |